Enveric Biosciences Inc (ENVB)
0.79
-0.03
(-3.72%)
USD |
NASDAQ |
May 15, 15:55
Enveric Biosciences Total Return Price: 0.79 for May 15, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| May 14, 2024 | 0.8205 |
| May 13, 2024 | 0.8406 |
| May 10, 2024 | 0.89 |
| May 09, 2024 | 0.92 |
| May 08, 2024 | 0.98 |
| May 07, 2024 | 0.89 |
| May 06, 2024 | 0.92 |
| May 03, 2024 | 0.98 |
| May 02, 2024 | 0.9255 |
| May 01, 2024 | 0.9298 |
| April 30, 2024 | 0.94 |
| April 29, 2024 | 0.9498 |
| April 26, 2024 | 0.895 |
| April 25, 2024 | 0.90 |
| April 24, 2024 | 0.934 |
| April 23, 2024 | 0.8974 |
| April 22, 2024 | 0.861 |
| April 19, 2024 | 0.8806 |
| April 18, 2024 | 0.938 |
| April 17, 2024 | 0.882 |
| April 16, 2024 | 0.911 |
| April 15, 2024 | 0.9215 |
| April 12, 2024 | 1.01 |
| April 11, 2024 | 0.9103 |
| April 10, 2024 | 0.9282 |
| Date | Value |
|---|---|
| April 09, 2024 | 0.9412 |
| April 08, 2024 | 0.9201 |
| April 05, 2024 | 0.93 |
| April 04, 2024 | 0.951 |
| April 03, 2024 | 1.01 |
| April 02, 2024 | 1.14 |
| April 01, 2024 | 0.89 |
| March 28, 2024 | 1.00 |
| March 27, 2024 | 1.02 |
| March 26, 2024 | 1.06 |
| March 25, 2024 | 1.05 |
| March 22, 2024 | 1.13 |
| March 21, 2024 | 1.17 |
| March 20, 2024 | 1.17 |
| March 19, 2024 | 1.19 |
| March 18, 2024 | 1.10 |
| March 15, 2024 | 1.08 |
| March 14, 2024 | 1.10 |
| March 13, 2024 | 1.16 |
| March 12, 2024 | 1.20 |
| March 11, 2024 | 1.32 |
| March 08, 2024 | 1.41 |
| March 07, 2024 | 1.52 |
| March 06, 2024 | 1.38 |
| March 05, 2024 | 1.41 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
0.742
Minimum
Jan 31 2024
1841.00
Maximum
Jun 17 2019
226.09
Average
85.75
Median
Total Return Price Benchmarks
| Seelos Therapeutics Inc | 0.2913 |
| Societal CDMO Inc (DELISTED) | 1.10 |
| Cardiff Oncology Inc | 3.56 |
| BioVie Inc | 0.4963 |
| Adial Pharmaceuticals Inc | 1.37 |